National Medicines Information Centre (NMIC) (@nationalnmic) 's Twitter Profile
National Medicines Information Centre (NMIC)

@nationalnmic

Promoting the safe, effective and efficient use of medicines. Retweets are not endorsements. Not 24/7, please email enquiries to [email protected]

ID: 1067721483949170688

linkhttp://www.nmic.ie calendar_today28-11-2018 10:06:53

438 Tweet

1,1K Followers

221 Following

National Medicines Information Centre (NMIC) (@nationalnmic) 's Twitter Profile Photo

Check out our most recent NMIC Bulletin on Breast cancer and adjuvant endocrine therapy,  March 2024, Vol 30, No 1,  at nmiccomms.newsweaver.com/hb4gz6mh51/1vv…

HPRA (@thehpra) 's Twitter Profile Photo

Our latest Drug Safety Newsletter provides updates for healthcare professionals to support the safe and appropriate use of these medicines: → Valproate (Epilim): New precautionary measures for fathers taking the medicine in the three months before conception → NSAIDs:

Our latest Drug Safety Newsletter provides updates for healthcare professionals to support the safe and appropriate use of these medicines:

→ Valproate (Epilim): New precautionary measures for fathers taking the medicine in the three months before conception

 → NSAIDs:
National Medicines Information Centre (NMIC) (@nationalnmic) 's Twitter Profile Photo

Check out on most recent NMIC bulletin #NMICbulletin ‘Prostate Cancer Survivorship and Androgen Deprivation Therapy’ Vol 30, No.2. (April 2024) at nmiccomms.newsweaver.com/hb4gz6mh51/w5l…

National Medicines Information Centre (NMIC) (@nationalnmic) 's Twitter Profile Photo

The May edition of the NMIC newsletter Therapeutics Today #NMICTT is now available athttps://nmiccomms.newsweaver.com/14ig36yfht/1x6fqz7xdhp. Check it out for information on risk of adverse events after initiation of AHT in older people; risk of serious falls and opioids.

National Medicines Information Centre (NMIC) (@nationalnmic) 's Twitter Profile Photo

Check out our most recent NMIC Bulletin #NMICbulletin ‘Use of medicines with anticholinergic activity’, Vol 30, No.3 May 2024 at nmiccomms.newsweaver.com/hb4gz6mh51/tmv…

IIoP (@iiopharmacy) 's Twitter Profile Photo

The IIOP are delighted to have collaborated with the NCCP on the creation of this important resource for pharmacists caring for patients with cancer The Hub is now live on the IIOP website➡️iiop.ie/content/cancer…   #WorldPharmacistDay #CancerCareHub NCCP Michelle O'Driscoll

The IIOP are delighted to have collaborated with the NCCP on the creation of this important resource for pharmacists caring for patients with cancer

The Hub is now live on the IIOP website➡️iiop.ie/content/cancer…
  #WorldPharmacistDay #CancerCareHub <a href="/hseNCCP/">NCCP</a>  <a href="/michelleodris/">Michelle O'Driscoll</a>
HPRA (@thehpra) 's Twitter Profile Photo

Our latest Drug Safety Newsletter offers valuable updates for healthcare professionals aimed at promoting the safe and effective use of medications. This edition features articles on: → The inadvertent ocular exposure to chlorhexidine during surgical site preparation → The

Our latest Drug Safety Newsletter offers valuable updates for healthcare professionals aimed at promoting the safe and effective use of medications. 

This edition features articles on:

→ The inadvertent ocular exposure to chlorhexidine during surgical site preparation
→ The
HPRA (@thehpra) 's Twitter Profile Photo

Our latest Drug Safety Newsletter provides healthcare professionals with information for using medicines safely and effectively. This edition includes: → Updates on pregnancy outcomes with fluconazole and advice for women who could become pregnant → EU review begins on the

Our latest Drug Safety Newsletter provides healthcare professionals with information for using medicines safely and effectively. 

This edition includes:

→ Updates on pregnancy outcomes with fluconazole and advice for women who could become pregnant

→ EU review begins on the
HPRA (@thehpra) 's Twitter Profile Photo

Our latest Drug Safety Newsletter offers healthcare professionals essential information on safe and effective use of medicines. It includes information on: → Finasteride and Dutasteride: Outcome of EU review on risk of suicidal ideation → Bilastine (oral): New warning about

Our latest Drug Safety Newsletter offers healthcare professionals essential information on safe and effective use of medicines. It includes information on:

→ Finasteride and Dutasteride: Outcome of EU review on risk of suicidal ideation
→ Bilastine (oral): New warning about